You are here: All Products  > AnHeart Raises $20 Million for ROS1/NTRK Inhibitor to Treat NSCLC

AnHeart Raises $20 Million for ROS1/NTRK Inhibitor to Treat NSCLC

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products